Image of the Day: Leprosy Lesion

Researchers identify two blood-clotting proteins that could be biomarkers for cardiovascular reactions in patients with leprosy.

Written byThe Scientist
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A vein surrounded by inflammatory cells and fluid, observed in a skin lesion of a leprosy patient FA LARA ET AL.

Some leprosy patients have an elevated risk of developing blood clots that can lead to stroke or heart attack. In a study published yesterday (March 22) in PLOS Neglected Tropical Diseases, researchers identify abnormal levels of several blood clotting factors in leprosy patients that could serve as predictive biomarkers for cardiovascular events.

Flavio Alves Lara, a biologist at the Oswaldo Cruz Institute, and colleagues took blood samples from leprosy patients who had unusually fatty blood clots, which the researchers call “leprosum clots.” They found that patients with leprosum clots had increased levels of a number of different proteins, compared to blood clots from patients who did not have leprosy.

D. Santos da Silva et al., “Blood coagulation abnormalities in multibacillary leprosy patients,” PLOS Negl Trop ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies